Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Aurobindo Pharma Ltd. (ARBN)

BSE
Currency in INR
Disclaimer
1,112.75
+26.90(+2.48%)
Closed

ARBN Comments

Update AUROPHARMA Revised Stop Loss 1000 from 980
soon will reach 1350
will reach 950 in the next 3 months
800 if you want
598
buy Aurobindo pharma target 550 shortly target....
Delivery : Buy Auropharma Above 448 Stop Loss 428 Targets 470-480
Buy Aurobindo pharma @458.55 CMP target 470, 480. Now it's bottom. Upside movement started with shortly
Money laundering case against the director… arrested
Director of the company auro pharma arrested by ED
sell on rise for 250,arbn on the way on irctc,yes bank.
Auropharma Revised SL 536 from 525 made high 551.4 as of now
Book Profit in Auropharma our Target 555+ Reached.. 👍
What is the price at which we can buy this now?
TP 700
Buy Aurobindo Pharma tgt 1000
600 coming game on by operators keep shorting 🤣
short this auro..seems it will reach till 610 level and see more selling pressure seen by fii and in this process promoter pledge shares may invoke by bank and bank may sell it to FII for cheaper rates..looks big game plan..unsure auro have what in basket..they tried some and even ipl but none worked..simply short and Start getting money rain
any view about this stock
its corrected 33% ..try to buy PE may be best of luck
seems it is bottomed out..let us see how it move
I'm already in buying at 872 level in future. what should I do? should I book loss aur hold with some stop loss
I am alo but at lower lto 749. I can't guess. due to usfda price slashed down. also ranitadine sell stopped.
dont trap on this.. dont enter below 810..only enter after 810 closing basis
Buy for tgt 800 this week
any suggestion regarding this stock
did you know Aurobindo is 2 largest listed company in term of revenue after Sun Pharma.. but sadly market capitalisation place was 10th place ...it is yet cheaper you getting this price..treat at as gem
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.